- In March 2026, UiPath expanded its agentic AI platform with new industry-specific solutions for purchase-to-pay, retail, manufacturing, and financial services, and broadened CTO Raghu Malpani’s remit to Chief Product and Technology Officer while also filing a US$356.70 million Class A common stock shelf registration tied to an ESOP offering.
- By layering AI agents and orchestration via its Maestro platform on top of existing enterprise systems, UiPath is positioning its automation stack deeper into customers’ core finance, pricing, compliance, and inventory workflows.
- We’ll now examine how UiPath’s new agentic AI solutions for purchase-to-pay and industry workflows may reshape its existing investment narrative.
Explore 25 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
UiPath Investment Narrative Recap
To own UiPath today, you need to believe its shift from classic RPA to an agentic AI orchestration platform can keep deepening adoption across large enterprises despite slower forecast revenue growth and near term earnings pressure. The March 2026 launch of industry specific AI agents and the expanded product and technology leadership look supportive of this thesis, but they do not immediately remove near term risks around deal timing, macro cautiousness, and FX headwinds.
Among the latest announcements, the UiPath Solution for Purchase to Pay looks especially relevant because it puts Maestro and AI agents directly into finance back office workflows where customers already feel pain from fragmented ERP and approval processes. If P2P and adjacent financial workflows see healthy uptake, that could reinforce the existing catalyst around expanding use of agentic products on top of UiPath’s installed base, even as the SaaS transition and timing of AI monetization remain important watchpoints.
Yet investors should also weigh how increasing competition in agentic AI orchestration from system of record vendors and AI native providers could pressure Maestro adoption and pricing...
Read the full narrative on UiPath (it's free!)
UiPath's narrative projects $2.1 billion revenue and $147.2 million earnings by 2029.
Uncover how UiPath's forecasts yield a $13.80 fair value, a 25% upside to its current price.
Exploring Other Perspectives
Some of the most optimistic analysts were assuming UiPath could reach about US$2.1 billion of revenue and roughly US$204 million of earnings by 2029, yet the new agentic solutions also highlight how much depends on complex, regulated use cases scaling smoothly rather than stalling if integration and partner led projects take longer than expected.
Explore 11 other fair value estimates on UiPath - why the stock might be worth just $13.80!
Reach Your Own Conclusion
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your UiPath research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
- Our free UiPath research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate UiPath's overall financial health at a glance.
Want Some Alternatives?
Our top stock finds are flying under the radar-for now. Get in early:
- The latest GPUs need a type of rare earth metal called Terbium and there are only 27 companies in the world exploring or producing it. Find the list for free.
- The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
- Invest in the nuclear renaissance through our list of 94 elite nuclear energy infrastructure plays powering the global AI revolution.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com